Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years.

Sibi Thiyagarajan, Elizabeth Wall-Wieler, Yuki Liu, Feibi Zheng, Michael Edwards